Moderna’s Cancer Vaccine Scores in a Clinical Trial
[The Motley Fool, Getty Images] Early-stage clinical trial results suggest adding mRNA-4157 to Keytruda can improve response rates. Moderna (NASDAQ:MRNA) announced encouraging results from a clinical trial with an experimental cancer vaccine. Treatment with the messenger RNA-based candidate, mRNA-4157, shrank tumors for five out of ten patients with head and neck squamous […]